Ágnes Benedict

1.6k total citations
57 papers, 1.2k citations indexed

About

Ágnes Benedict is a scholar working on Economics and Econometrics, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ágnes Benedict has authored 57 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Economics and Econometrics, 16 papers in Oncology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ágnes Benedict's work include Health Systems, Economic Evaluations, Quality of Life (22 papers), Economic and Financial Impacts of Cancer (15 papers) and Cancer Treatment and Pharmacology (8 papers). Ágnes Benedict is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (22 papers), Economic and Financial Impacts of Cancer (15 papers) and Cancer Treatment and Pharmacology (8 papers). Ágnes Benedict collaborates with scholars based in United States, United Kingdom and Germany. Ágnes Benedict's co-authors include N. Muszbek, A. Keskinaslan, Zeba Khan, Joyce A. Cramer, K. Jack Ishak, Noémi Kreif, Irina Proskorovsky, Michael E. Stokes, Libby Black and Diana Brixner and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Ágnes Benedict

53 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ágnes Benedict United States 18 418 283 243 221 143 57 1.2k
James Chan United States 18 141 0.3× 139 0.5× 173 0.7× 87 0.4× 192 1.3× 29 947
Jennifer Sung United States 22 146 0.3× 356 1.3× 182 0.7× 231 1.0× 452 3.2× 46 1.6k
Lucie Kutikova Switzerland 16 335 0.8× 315 1.1× 80 0.3× 129 0.6× 101 0.7× 53 1.0k
Theresa Shao United States 12 185 0.4× 764 2.7× 524 2.2× 313 1.4× 80 0.6× 30 1.8k
Pengxiang Li United States 21 558 1.3× 87 0.3× 212 0.9× 153 0.7× 23 0.2× 70 1.4k
Steven T. Fleming United States 21 483 1.2× 561 2.0× 38 0.2× 145 0.7× 62 0.4× 66 1.4k
Alice Dragomir Canada 27 505 1.2× 300 1.1× 595 2.4× 446 2.0× 175 1.2× 95 2.2k
Lee N. Newcomer United States 18 486 1.2× 356 1.3× 212 0.9× 149 0.7× 13 0.1× 59 1.4k
N. Muszbek United Kingdom 10 237 0.6× 98 0.3× 246 1.0× 75 0.3× 142 1.0× 35 805
Melissa Accordino United States 18 115 0.3× 445 1.6× 91 0.4× 222 1.0× 25 0.2× 98 905

Countries citing papers authored by Ágnes Benedict

Since Specialization
Citations

This map shows the geographic impact of Ágnes Benedict's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ágnes Benedict with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ágnes Benedict more than expected).

Fields of papers citing papers by Ágnes Benedict

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ágnes Benedict. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ágnes Benedict. The network helps show where Ágnes Benedict may publish in the future.

Co-authorship network of co-authors of Ágnes Benedict

This figure shows the co-authorship network connecting the top 25 collaborators of Ágnes Benedict. A scholar is included among the top collaborators of Ágnes Benedict based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ágnes Benedict. Ágnes Benedict is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Benedict, Ágnes, et al.. (2024). Life Years Gained From the FDA Accelerated Approval Program in Oncology: A Portfolio Model. Journal of the National Comprehensive Cancer Network. 22(6). 382–389. 2 indexed citations
3.
Bullement, Ash, Simon J. Crabb, Robert J. Jones, et al.. (2023). Cost–effectiveness analysis for avelumab first-line maintenance treatment of advanced urothelial carcinoma in Scotland. Future Oncology. 20(8). 459–470.
4.
5.
Benedict, Ágnes, Emily R. Hankosky, Jieling Chen, et al.. (2022). A Framework for Integrating Continuous Glucose Monitor-Derived Metrics into Economic Evaluations in Type 1 Diabetes. PharmacoEconomics. 40(8). 743–750. 1 indexed citations
6.
7.
8.
Marsh, Kevin, et al.. (2014). Model-Based Cost-Effectiveness Analyses for the Treatment of Chronic Myeloid Leukaemia: A Review and Summary of Challenges. PharmacoEconomics. 32(9). 853–864. 5 indexed citations
9.
Ishak, K. Jack, Noémi Kreif, Ágnes Benedict, & N. Muszbek. (2013). Overview of Parametric Survival Analysis for Health-Economic Applications. PharmacoEconomics. 31(8). 663–675. 88 indexed citations
10.
Sorensen, Sonja, Feng Pan, Connie Chen, et al.. (2012). INCIDENCE-BASED COST-OF-ILLNESS MODEL FOR METASTATIC BREAST CANCER IN THE UNITED STATES. International Journal of Technology Assessment in Health Care. 28(1). 12–21. 62 indexed citations
11.
Benedict, Ágnes, Robert A. Figlin, Per Sandström, et al.. (2011). Economic evaluation of new targeted therapies for the first‐line treatment of patients with metastatic renal cell carcinoma. British Journal of Urology. 108(5). 665–672. 37 indexed citations
12.
Stokes, Michael E., Libby Black, Ágnes Benedict, Claus G. Roehrborn, & Peter C. Albertsen. (2010). Long-term medical-care costs related to prostate cancer: estimates from linked SEER-Medicare data. Prostate Cancer and Prostatic Diseases. 13(3). 278–284. 26 indexed citations
13.
Benedict, Ágnes, L Verdian, & Grant Maclaine. (2010). The Cost Effectiveness of Rufinamide in the Treatment of Lennox-Gastaut Syndrome in the UK. PharmacoEconomics. 28(3). 185–199. 19 indexed citations
14.
Järbrink, Krister, Noémi Kreif, Ágnes Benedict, & Julie Locklear. (2009). Quality of life and drug costs associated with switching antipsychotic medication to once-daily extended release quetiapine fumarate in patients with schizophrenia. Current Medical Research and Opinion. 25(3). 709–716. 9 indexed citations
15.
Benedict, Ágnes, et al.. (2009). Economic evaluation of duloxetine versus serotonin selective reuptake inhibitors and venlafaxine XR in treating major depressive disorder in Scotland☆. Journal of Affective Disorders. 120(1-3). 94–104. 24 indexed citations
16.
Fourcade, R., Ágnes Benedict, Libby Black, et al.. (2009). Treatment costs of prostate cancer in the first year after diagnosis: a short‐term cost of illness study for France, Germany, Italy, Spain and the UK. British Journal of Urology. 105(1). 49–56. 53 indexed citations
17.
Muszbek, N., Diana Brixner, Ágnes Benedict, A. Keskinaslan, & Zeba Khan. (2008). The economic consequences of noncompliance in cardiovascular disease and related conditions: a literature review. International Journal of Clinical Practice. 62(2). 338–351. 71 indexed citations
18.
19.
Cramer, Joyce A., Ágnes Benedict, N. Muszbek, A. Keskinaslan, & Zeba Khan. (2007). The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review. International Journal of Clinical Practice. 62(1). 76–87. 389 indexed citations
20.
Benedict, Ágnes & Ruth E. Brown. (2005). Review of cost-effectiveness analyses in hormonal therapies in advanced breast cancer. Expert Opinion on Pharmacotherapy. 6(11). 1789–1801. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James Chan Breakdown of academic impact, for papers by Jennifer Sung Breakdown of academic impact, for papers by Lucie Kutikova Breakdown of academic impact, for papers by Theresa Shao Breakdown of academic impact, for papers by Pengxiang Li Breakdown of academic impact, for papers by Steven T. Fleming Breakdown of academic impact, for papers by Alice Dragomir Breakdown of academic impact, for papers by Lee N. Newcomer Breakdown of academic impact, for papers by N. Muszbek Breakdown of academic impact, for papers by Melissa Accordino
Rankless by CCL
2026